DWF: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass
What it covers
A cardiopulmonary bypass vascular catheter, cannula, or tubing is a device used in cardiopulmonary surgery to cannulate the vessels, perfuse the coronary arteries, and to interconnect the catheters and cannulas with an oxygenator. The device includes accessory bypass equipment.
The identification in 21 CFR 870.4210, cardiopulmonary bypass vascular catheter, cannula, or tubing. FDA gives DWF no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K263092 | Dual Stage Venous Cannulae | Sorin Group Italia S.R.L. | Oct 1, 2026 | Special |
| K262052 | Tri Stage Venous Cannulae | Sorin Group Italia S.R.L. | Sep 28, 2026 | Traditional |
| K260195 | Elongated One-Piece Arterial (EOPA) 3D Arterial Cannulae | Medtronic, Inc. | Apr 23, 2026 | Special |
| K250937 | Venous Return Cannulae | LivaNova USA, Inc. | Mar 11, 2026 | Traditional |
| K260043 | Smart Reactors Camouflage Coated Extracorporeal Cardiopulmonary Tubing Set (SR180C) | Smart Reactors | Feb 23, 2026 | Traditional |
| K253203 | Retrograde Coronary Sinus Perfusion Cannulae | Medtronic, Inc. | Feb 19, 2026 | Traditional |
| K253671 | Dual Stage Venous Cannulae | Sorin Group Italia S.R.L. | Jan 30, 2026 | Traditional |
| K253998 | Clearview Intracoronary Shunts | Medtronic, Inc. | Jan 20, 2026 | Special |
| K253106 | AngioVac Cannula | AngioDynamics, Inc. | Oct 24, 2025 | Special |
| K250283 | RAP Femoral Venous Cannulae | LivaNova USA, Inc. | Jul 10, 2025 | Special |
Clearances by year
90 DWF 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 8 | 81 |
| 2025 | 4 | 89 |
| 2024 | 3 | 29 |
| 2023 | 2 | 127 |
| 2022 | 2 | 147 |
| 2021 | 5 | 358 |
| 2020 | 3 | 30 |
| 2019 | 3 | 120 |
| 2018 | 5 | 30 |
| 2017 | 5 | 127 |
| 2016 | 3 | 32 |
| 2015 | 9 | 46 |
| 2014 | 14 | 110 |
| 2013 | 9 | 110 |
| 2012 | 10 | 110 |
| 2011 | 5 | 85 |
Who submits
23 applicants cleared a DWF device since 2011. 79% of the clearances went to applicants in United States, then Italy (14%), Germany (4%) and Ireland (1%). By type: Traditional 56% and Special 44%.
| Applicant | Clearances since 2011 |
|---|---|
| Medtronic, Inc. | 30 |
| Edwards Lifesciences, LLC | 11 |
| Sorin Group Italia S.R.L. | 8 |
| Cardiacassist, Inc. | 7 |
| AngioDynamics, Inc. | 4 |
| Maquet Cardiopulmonary, AG | 4 |
| Qura S.R.L | 4 |
| Cardiogard Medical, Ltd. | 2 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.4210.
Standards
21 CFR 870.4210 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DWF clearances declared.
Ask about DWF
Questions about DWF
What is FDA product code DWF?
Product code DWF, “Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass” in FDA's classification database, is a Class II device type under 21 CFR 870.4210 (cardiopulmonary bypass vascular catheter, cannula, or tubing), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 403 clearances under DWF, 90 of them since 2011.
How many 510(k) clearances are there under DWF?
FDA’s 510(k) database listed 403 clearances under DWF as of Oct 29, 2026, 90 of them decided since 2011; the most recent decision was Oct 1, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DWF 510(k)?
For the 12 DWF clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 81 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DWF clearances?
Since 2011: Medtronic, Inc. (30), Edwards Lifesciences, LLC (11), Sorin Group Italia S.R.L. (8), Cardiacassist, Inc. (7) and AngioDynamics, Inc. (4). 23 applicants have cleared a DWF device in that time.